# Testing a Transdiagnostic TMS Treatment Target

> **NCT06282146** · EARLY_PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **Brigham and Women's Hospital** · enrollment: 10 (estimated)

## Conditions studied

- Major Depressive Disorder
- Depression
- Psychiatric Disorder
- Mood Disorders
- Mental Disorder
- Anxiety Disorders
- OCD
- PTSD

## Interventions

- **PROCEDURE:** transcranial magnetic stimulation

## Key facts

- **NCT ID:** NCT06282146
- **Lead sponsor:** Brigham and Women's Hospital
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-09-09
- **Primary completion:** 2025-05-23
- **Final completion:** 2026-05-01
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2025-06-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06282146

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06282146, "Testing a Transdiagnostic TMS Treatment Target". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT06282146. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*